巴伊卡林通过RAGE/PXDN/PI3K/AKT途径影响糖尿病视网膜病变的进展
Yi Gao1,2, Huirui Liu1,2, Tao Yang3
1Eye Hospital, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Journal of translational medicine
|December 18, 2025
概括
贝卡林 (BAI) 通过向RAGE/PXDN-FN1/PI3K/AKT通路来抑制糖尿病视网膜病变 (DR) 的进展,减少病理血管生成和细胞衰老.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 糖尿病视网膜病变 (DR) 是成人失明的主要原因.
- 病原发生涉及微血管的增殖,导致视力丧失.
- 在DR.中研究过氧素 (PXDN) 和素 (BAI).
研究的目的:
- 研究PXDN和BAI在DR中的作用和分子机制.
- 确定DR进展中的关键基因和信号通路.
- 探索BAI对人类视网膜微血管内皮细胞 (HRMEC) 的影响.
主要方法:
- 选了枢纽基因并分析了PXDN,纤维素 (FN1) 和PI3K/AKT通路蛋白.
- 经过分子对接和西方斑点,经过验证的BAI与RAGE结合.
- 使用基因淘汰/过度表达和西部斑点来研究BAI对RAGE/PXDN(FN1) /PI3K/AKT通路的影响.
主要成果:
- 在DR模型中,PXDN表达增加.
- PXDN与FN1直接相互作用.
- BAI通过与RAGE结合来抑制PXDN和FN1,通过PI3K/AKT通路调节缓解HRMEC衰老和血管生成.
结论:
- BAI通过RAGE/PXDN(FN1)/PI3K/AKT通路调节DR的进展.
- 提供了对DR病变发生的分子洞察力.
- 为新的DR治疗策略奠定了基础.
更多相关视频
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
Insulin: The Receptor and Signaling Pathways
2.6K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.6K
Dipeptidyl Peptidase 4 Inhibitors
557
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
557
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K


